Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial

Alan R. Kristal, Douglas K. Price, Cathee Till, Jeannette M. Schenk, Marian L. Neuhouser, Sandy Ockers, Daniel W. Lin, Ian M. Thompson, William D. Figg

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial'. Together they form a unique fingerprint.

Medicine & Life Sciences